All Type of News
Kuhnil to introduce anticancer drug from Taiwan
Kuhnil Phar has signed an exclusive agreement with Taiwan-headquartered TTY BioPharm to distribute an anticancer medicine, Lipo-Dox (pegylated liposomal doxorubicin), in Korea.
Doxorubicin is a chemotherapy drug. I...
Green Cross targets W10 billion in child's nutrition market
Green Cross Corporation plan to target the annual sales of its nutrient product Tirano Gold up to 10 billion won, now that it is becoming popular among young housewives.
According to a company official, the three-...
KFDA reaffirms implementation of new GMP regulation within this year
The Korea Food and Drug Administration is firm in implementing the new cGMP (current good manufacturing practice) regulation at the year-end at the latest, which it says cannot be delayed as it will lay the foundation...
Patent dispute on Ultracet seen intensifying
With 10 local pharmaceutical firms filing their nullification trial over Ultracet (tramadol HCl + acetaminophen) of Janssen Korea, Hanmi Pharm has also followed the suit with its revised patent on November 8.
Ultr...
Korean scientists invent new photosensitizer synthesizing method
A group of Korean scientists led by Chonnam University have successfully developed a method of synthesizing 'transdermally available 5-amino-levulinic acid (5-ALA) unsaturated alkyl ester and its pharmaceutically acce...
Korea likely to face foreign competition in generic drug market
Indian generic markers will be poised to enter the Korean pharmaceutical market as situation will permit, market experts said.
They argued that the Korea-U.S. free trade agreement is expected to make it easier for ...
Ildong gets exclusive right for paclitaxel PM technology
Ildong Pharm has recently obtained an exclusive license for developing paclitaxel PM product and its delivery system in a strategic partnership with a Chinese company that received a Chinese patent in January of this ...
Foreign drug makers fear disgraced corporate image over rebate scandal
With the Fair Trade Commission's second announcement of rebate scandal involving several foreign-invested pharmaceutical firms, there are growing concerns that the commission's disclosure will tarnish the reliability ...
KPTA calls for delay of drug standard code after 2009
The Korea Pharmaceutical Manufacturers Association has asked the Ministry of Health and Welfare to defer the government's standardized drug bar-code (KD code) plan after 2009.
The association said in a statement th...
Oriental pharmacists seek unified pharmacist system
We have no choice but to advocate a unified pharmacist system for the protection of oriental pharmacists, said an official at the Association of Oriental Pharmacy.
Park Seok Jae, an administrative director of the a...
